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The formation of influenza virus ribonucleoprotein (RNP) is a necessary step in viral assembly and maturation in infected
cells, but the mechanism remains incompletely understood. Influenza virus proteins such as matrix (M1) and cellular proteins
have been implicated in assembly and transport of RNP. To study the assembly of RNP and the translocation of RNP
complexes in cells, RNPs were reconstituted from nucleoprotein (NP), M1, and viral RNA (vRNA) synthesized in vitro. The
syntheses were accomplished using specific plasmids in a system coupling transcription and translation under the control
of the T7 promoter. The density of the resulting RNP complexes was analyzed by glycerol gradient centrifugation and the
morphology was examined by transmission electron microscopy. Protomers of NP self-assembled into circular oligomers
regardless of the presence of vRNA or M1. However, helical structures similar in conformation and density to RNPs purified
directly from influenza virus were formed only when M1 and vRNA were also present. In the absence of vRNA, no helical
structures were formed from NP and M1. The plasmids also contained the CMV promoter, which permitted expression of M1,
NP, and vRNA in Madin–Darby canine kidney (MDCK). M1 and NP were both present in the cytoplasm of MDCK also
expressing vRNA, but NP was retained in the nucleus of cells expressing M1 without vRNA. Our data demonstrate for the
first time that vRNA and M1 together promote the self-assembly of influenza virus NP into the quaternary helical structure
typical of the viral RNP. The results also indicate that the interaction of NP with vRNA and M1 in a system devoid of other
viral proteins can lead to translocation of RNP from nucleus to cytoplasm.
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The influenza A virus has a genome that consists of
eight single-strand, negative-sense viral RNAs (vRNA)
which are packaged in the form of ribonucleoprotein
(RNP) segments (Heggeness et al., 1982; Lamb and
Choppin, 1983; Murti et al., 1988). Matrix protein (M1), the
major structural protein in the viral particle, is located
between the RNPs and the inner surface of the lipid
envelope in the intact virion (Allen et al., 1980; Compans
and Klenk, 1979; Lamb and Choppin, 1983; Schulze,
1972). Two major external glycoproteins, hemagglutinin
(HA) and neuraminidase (NA), and a small transmem-
brane protein (M2) are inserted into the viral envelope
(Lamb and Zeebedee, 1985; Sugrue and Hay, 1991; Zee-
bedee and Lamb, 1988). During early viral replication, the
dissociation of M1 from RNPs permits entry of the RNPs
into the host cell nucleus, where new viral RNA transcrip-
tion occurs (Bui et al., 1996, 2000). It has been shown
also that M1 is transported from the cytoplasm into the
nucleus during early viral replication (Rey and Nayak,
1992). Later in the replication cycle, the accumulation of
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405M1 in the cytoplasm is concomitant with the nuclear
export of RNP (Bui et al., 1996, 2000; Herz et al., 1981;
Krug et al., 1989; Martin and Helenius, 1991; Silver, 1991).
The structure of RNPs present in influenza virions has
been studied in detail by electron microscopy (Compans
et al., 1972; Heggeness et al., 1982; Jennings et al., 1983;
Klumpp et al., 1997; Pons et al., 1969; Pons, 1971; Ruigrok
and Baudin, 1995; Schulze, 1972). From these studies,
RNP is interpreted to consist of a helical structure with a
terminal loop formed by a bend in the middle of the RNA.
Nucleoprotein (NP), the most abundant viral protein after
M1, binds viral RNA without sequence specificity and
protects the sugar-phosphate backbone of the RNA from
modification (Baudin et al., 1994; Ortega et al., 2000). RNP
reconstituted using NP recovered from virus and viral
RNA synthesized in vitro is structurally and biochemically
similar to the native viral RNP (Kingsbury et al., 1987;
Yamanake et al., 1990). Although RNA-free NP can as-
semble into structures that are indistinguishable in form
from the intact RNP of the influenza virion, artificially high
protein concentration and low temperature are needed
for the formation to develop (Ruigrok and Baudin, 1995).
What triggers the formation of helical structure of RNP
under physiological condition remains unclear.The interactions of M1 with RNP have been studied
extensively (Baudin et al., 2001; Compans et al., 1972; Rees
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406 HUANG ET AL.and Dimmock, 1982; Ruigrok and Baudin, 1995; Schulze,
1972, 1973;Ye et al., 1999). The amino acid sequences of M1
needed for binding to RNP have been studied using RNP
isolated from virions and M1 synthesized in vitro (Ye et al.,
1987, 1999). With RNP isolated from virions and M1 synthe-
sized in vitro, M1 binds to RNP not only by specific binding
sites for viral RNA but also by what appears to be direct
interaction of M1 with NP. In cells infected with influenza
virus, M1 may facilitate the transport of RNP complexes
from the nucleus into the cytoplasm (Bui et al., 1996, 2000)
and prevent RNP from reentering the nucleus (Martin and
Helenius, 1991). Although this suggests that M1 is neces-
sary for RNP export (Bui et al., 1996, 2000), the experimental
ystem used previously did not eliminate the possibility that
ther viral proteins, such as NS2, also contribute to the
bserved translocations of RNP (Neumann et al., 2000;
’Neill et al., 1998). Experimental evidence now exists to
ndicate that multiple mechanisms may contribute to nu-
lear export of RNP with participation of M1, NS2, and
ellular proteins such as chromosome region maintenance
protein (CRM1) (Neumann et al., 2000; Elton et al., 2001).
In the studies reported here, we demonstrate a require-
ment for viral RNA in the self-assembly and translocation of
NP. These studies, which are based on a reductionist sys-
tem in which NP, M1, and viral RNA are expressed from
specific plasmids, also examine the interactions of NP, M1,
and vRNA in the formation of helical RNP structures and
export of RNP from the cellular nucleus.
RESULTS
Construction, expression, and characterization of NP,
M1, and viral RNA
FIG. 1. Schematic representation of the construction of the pCR3.1-d
(pCR-NP), M1 (pCR-M), or M vRNA alone (pCR-vRNA). For expression of
sequence coding for vRNA. The expression of the genes was driven bFigure 1 shows schematic models of the constructs
coding for NP plus M vRNA (pCR-NP-vRNA), for NP alone(pCR-NP), for M1 (pCR-M), and for M vRNA alone (pCR-
vRNA). In the constructs, which also incorporated the
CMV promoter, the T7 promoter was used to control in
vitro transcription of vRNA and in vitro translation of NP
and M1. Release of the mature negative-sense vRNA for
the seventh gene segment (M, which codes for M1 and
M2) was autocatalyzed by ribozyme sequences cloned
into both ends of the M gene.
NP and M1 were labeled with [35S]Met during in vitro
translation. As shown by electrophoresis in12% SDS–
polyacrylamide and autoradiography (Fig. 2A), a transla-
tion product approximately 56 kDa was derived from the
pCR-NP plasmid (lane 2), and a translation product of
approximately 28 kDa was derived from the pCR-M plas-
mid (lane 3). The identities of these translation products
of either NP or M1 were confirmed by using monoclonal
antibodies specific for NP and M1 (data not shown). The
PCR-M plasmid product appeared as a tight doublet in
autoradiography and within the immunoprecipitation. As
expected, the translation product from pCR-NP-vRNA
coding for the NP and negative-strand vRNA showed a
single 56-kDa protein band corresponding to NP (lane 4).
No protein was synthesized from the plasmid pCR-vRNA
coding for only vRNA of M (lane 1).
To detect expression of vRNA in our system, vRNA was
transcribed in the presence of [32P]UTP and processed
y ribozyme sequences in the plasmid constructs. Figure
B shows the 32P-labeled RNA fragments generated from
the plasmids. As an internal MW control, the pCR-vRNA
was linearized by restriction enzyme digestion at the
XbaI site at the downstream end of the negative-strand
M gene to result in synthesis of a full-length M gene
corresponding to the predicted size of 1027 nucleotides
vectors used for expression of NP and M vRNA (pCR-NP-vRNA), NP
a hairpin ribozyme sequence (RZ) was placed at both ends of the DNA
CMV and T7 promoters.erived(Fig. 2B, lane 1). Transcription of pCR-vRNA plasmid
linearized by AccI digestion at nucleotide position 776 in
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407RIBONUCLEOPROTEIN FORMATION AND NUCLEAR EXPORTthe M gene resulted in an RNA fragment corresponding
to the predicted size of 776 nucleotides (Fig. 2B, lane 2).
FIG. 2. Expression of NP and M1 and the maturation of transcribed
vRNA in vitro. (A) SDS–PAGE and autoradiography of NP translated in
vitro and labeled with [35S]Met from pCR-NP (lane 2) or from pCR-NP-
RNA (lane 4) and M1 from pCR-M plasmid (lane 3). As a negative
ontrol, a plasmid pCR-vRNA coding for vRNA was used in the tran-
cription-translation reaction (lane 1). (B) Autoradiography analysis of
ranscribed [32P]RNAs and the ribozyme activities in vRNA-procurers.
s internal RNA markers, RNAs labeled with [32P]UMP were tran-
scribed from pCR-vRNA plasmids linearized with XbaI at the 39 end of
vRNA coding region (pCR-vRNA-XbaI, lane 1) or linearized within the
vRNA coding region by AccI restriction enzyme at nucleotide 776
(pCR-vRNA-AccI, lane 2). The vRNAs labeled with [32P]UMP were tran-
cribed from plasmid coding for NP and vRNA (pCR-NP-vRNA, lane 3)
r from plasmid coding for vRNA alone (pCR-vRNA, lane 4).When transcription of plasmid pCR-NP-vRNA was car-
ried out, two predominant products appeared in the tran-scription reaction: an RNA approximately 1027 nucleo-
tides in length corresponding to the complete M vRNA
and an RNA approximately 1565 nucleotides in length
corresponding to the complete NP complementary RNA
(cRNA, Fig. 2B, lane 3). Transcription of pCR-vRNA also
resulted in the generation of an RNA product corre-
sponding to the predicted 1027 nucleotide size (Fig. 2B,
lane 4). These results indicated that the M vRNA tran-
scribed in vitro was processed correctly by the ribonu-
clease activity of ribozyme sequences.
Self-assembly of NP synthesized in vitro with or
without vRNA
As a preliminary stage of investigating NP self-assem-
bly, RNP complexes were purified from viral particles and
analyzed in 30–65% glycerol gradients under the same
conditions as that for reconstituted RNP complexes de-
scribed in following sections. For the RNP complexes
purified from virions, the highest concentration of NP
was in fraction 12, which also contained M1 and viral
polymerases (Fig. 3).
To investigate the effect of NP on influenza virus RNA,
the interaction of vRNA with NP was studied using NP
translated in vitro and the M vRNA transcribed in the
presence of [3H]UTP. M vRNA was transcribed from plas-
id pCR-vRNA in the presence of [3H]UTP. After incuba-
ion of radioactively labeled vRNA with or without NP, the
ixtures of NP and RNA were centrifuged in 30–65%
lycerol gradients to collect fractions for liquid scintilla-
ion counting. Figure 4 shows the gradient distribution of
3H]UTP-labeled materials from vRNA compared with
hat from vRNA and NP (vRNA 1 NP). For vRNA 1 NP,
adiolabeled vRNA was distributed in the gradient with a
istinct peak around the middle of the gradient (fraction
). However, for vRNA without NP, the radiolabeled vRNA
as distributed predominantly in upper portions of the
radient with decreasing activity in denser fractions.
hus, the distribution at higher density after incubation of
P with vRNA suggested that vRNA bound to NP.
FIG. 3. Glycerol gradient analysis of native RNP. The native RNP was
purified from A/PR8/34 influenza virus, centrifuged in a 30–65% glycerol
gradient for 16 h at 4°C, analyzed by SDS–PAGE, and stained with
Coomassie brilliant blue. T, top of the gradient; B, bottom of the
gradient.
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408 HUANG ET AL.The self-assembly of NP into RNP was investigated
using [35S]Met-labeled NP and M1 translated in vitro and
incubated with or without vRNA, as described under
Materials and Methods. Figure 5 illustrates the distribu-
tion profiles of NP and M1 after gradient centrifugation.
NP was distributed through most of the fractions, but the
peak of the NP was found in fraction 7 (Fig. 5A). We
observed no major differences in the distribution of the
NP in the presence of vRNA (Fig. 5B). In both cases, the
FIG. 4. Glycerol gradient analysis of the association of vRNA with NP.
The NP used for RNA association was prepared in the same manner as
that for the NP-assembly assay except without [35S]Met labeling.
3H]vRNA was synthesized in vitro from pCR-vRNA in a MEGAscript TM
system (Ambion). vRNA was purified using Sephadex G-50 columns.
The incorporation of [3H]UTP into RNAs was analyzed by measurement
of the ratio of RNA concentration and CPM (Ye et al., 1987). The
association of vRNA with NP was performed by incubation of 3H-
abeled vRNA (80,000 CMP) with (vRNA1NP) or without (vRNA) NP
nder the same conditions as that for polymerization. The sample was
entrifuged through 30–65% glycerol gradient for 16 h at 4°C and
ractionated. The radioactivity in the samples was analyzed by scintil-
ation counter.
FIG. 5. Glycerol gradient and SDS–PAGE analysis of polymerization
perform the polymerization of NP, NP was translated and labeled with
he presence of pCR-vRNA (A) or in the absence of pCR-vRNA plasmid (B). As a
f vRNA (D).peaks of NP were found in the middle of the gradient.
The lack of shift in quantity of NP to fraction 7, as was
shown for vRNA in Fig. 4, possibly related to reduced
sensitivity for detection of a shift because of the relatively
large amount of NP already in fraction 7. Unlike NP, M1
was distributed predominantly in fractions 2–4 of the
gradient, but similar to NP, the distribution of M1 was not
altered by the presence of vRNA (Figs. 5C and 5D). The
distribution of NP at higher density than M1 suggested
that under the experimental conditions NP formed oli-
gomers (even in the absence of M1 or vRNA). The dis-
tribution of NP in the gradients also indicated that even
if vRNA bound to NP, this binding activity per se did not
result in fully formed RNP similar in density to that re-
covered from virus (Fig. 3).
Association and effect of vRNA and M1 on self-
assembly of NP
It has been shown that M1 does not bind to NP when
both proteins are coexpressed in the same cell (Avalos
et al., 1996; Zhao et al., 1998), which suggests that other
factors are required for RNP assembly and maturation.
Since vRNA appeared to bind to NP oligomers at lower
density (Fig. 5) than native RNP and some M1 remains in
RNP recovered from virus (Fig. 3), we postulated a re-
quirement of both vRNA and M1 for full assembly of the
final RNP.
The distribution in glycerol gradients when NP and M1
were coexpressed with or without vRNA are shown in
Fig. 6. The pattern of the distribution of NP and M1 after
they were coexpressed in the absence of vRNA was
similar to the pattern seen for NP or M1 alone (compare
Fig. 6A with Fig. 5). In both instances, NP showed a peak
in fraction 7, and M1 showed a peak in fractions 1–4. In
nd M1 synthesized in vitro in the presence of or absence of vRNA. To
t in vitro from pCR-NP; in the same reaction, vRNA was transcribed inof NP a
[35S]Mecontrol, the M1 was also translated in the presence of (C) or absence
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409RIBONUCLEOPROTEIN FORMATION AND NUCLEAR EXPORTcontrast, coexpression of NP with M1 in the presence of
vRNA altered the distribution of NP and M1 in the gra-
dient and resulted in the appearance of NP and M1 in
fraction 12, similar to native RNP (see Fig. 3). Under the
same conditions, coexpression of NP with M1 in the
presence of nonspecific RNA neither altered the distri-
bution of NP and M1 in the gradient nor resulted in the
appearance of NP and M1 in fraction 12 (data not
shown). A relatively small proportion, approximately 5%,
of total NP recovered from the gradient was present in
fraction 12 (contrast Fig. 6B with Fig. 3). In addition, M1
was also shifted from a lower to a higher density in the
gradient (compare Figs. 6A and 6B), which suggested the
possibility of formation of intermediate complexes of NP
oligomers and M1 when vRNA was present.
Morphology of reconstituted NP and RNP
It has been shown that NP purified from virions forms
two major structures (Ruigrok and Baudin, 1995); one is
a simple circular structure and the other is a more com-
plex helical structure. The latter structural form repre-
sents the native RNP recovered from influenza virus.
Material prepared for earlier experiments was used to
confirm whether RNP complexes reconstituted from NP
FIG. 6. Effect of M1 on self-assembly of NP or NP/vRNA: Self-
assembly of NP and NP/vRNA in the presence of M1 was performed
the same as that in Fig. 5. Self-assembly of NP in the presence of M1
was performed by translation of NP and M1 in a reaction with the
pCR-NP and pCR-M plasmids (A). Self-assembly of NP/vRNA in the
presence of M1 was carried out by transcription and translation of NP,
M1, and vRNA in one reaction using pCR-NP-vRNA and pCR-M plasmid
(B). T, top of the gradient; B, bottom of the gradient.translated in vitro and vRNA transcribed in vitro repro-
duced the structure of native RNP. Fractions correspond-
i
sing to oligomers (fraction number 7 in Fig. 6) and RNP
(fraction number 12 in Fig. 6) were concentrated by
centrifugation, and the morphology of the quaternary
structure of the viral proteins in the fractions was exam-
ined by electron microscopy. Figure 7 shows represen-
tative results. Simple circular oligomers were found for
material derived from either pCR-NP-vRNA and pCR-M
(Fig. 7A) or pCR-NP and pCR-M (Fig. 7B). Helical struc-
tures similar to native virion RNP were formed only when
NP, M1, and vRNA were present in the same reaction
sample (Fig. 7C). Helical structures were not observed in
the sample containing NP and M1 in the absence of
vRNA (Fig. 7D). Self-assembled helical RNP (Fig. 7C) was
similar in structure to viral RNP (Fig. 7E). Aggregates
representing nonspecific products of the in vitro transla-
tion system were also found (Figs. 7C and 7D; compare
with control Fig. 7F). These results suggested that NP
forms simple circular oligomers either in the presence or
in the absence of vRNA, but interaction of NP with M1
and vRNA is needed to promote the formation of a higher
order helical structure of NP.
Effect of M1 and vRNA on the cellular distribution
of NP
In late stages of infection, viral RNPs are transported
from the nucleus to the cytoplasm before final viral par-
ticle assembly. Although it has been shown that NS2
protein of influenza virus is involved in export of RNP
(O’Neill et al., 1998), it has been suggested that M1 alone
an be sufficient for export of RNP from nucleus to
ytoplasm (Bui et al., 1996, 2000). However, the systems
sed previously to demonstrate the effect of M1 did not
xclude contributions of NS2 to the observed RNP export
Bui et al., 1996, 2000). Furthermore, recent studies sug-
est that NS2 or the cellular protein CRM1 alone can
romote export of NP under experimental conditions
Neumann et al., 2000; Elton et al., 2001).
Since the sequences coding for the M1 and NP and M
RNA were also under control of the CMV promoter, it
as possible to express M1, NP, or NP1vRNA in Madin-
arby canine kidney (MDCK) cells after transfection with
lasmids pCR-M, pCR-NP, or pCR-NP-vRNA. The M1 was
ransiently expressed in MDCK by transfection of the
CR-M plasmid for 16 h, whereas the NP or NP-vRNA
CMV/NP or CMV/NP-vRNA) was stably expressed in
DCK cells after transfection with pCR-NP or pCR-NP-
RNA and selection with geneticin. The expression of M1
r NP was confirmed by immunofluorescence using an-
ibodies to M1 or to NP. As shown in Fig. 8, when MDCK
ells were transfected with pCR-M for 16 h, the majority
f the M1 was located in the cell cytoplasm (Fig. 8A). The
istribution of NP in MDCK cells transfected with either
CR-NP (Fig. 8B) or pCR-NP-vRNA (Fig. 8C) was predom-nantly in the nuclei of the transfected cells. The expres-
ion of vRNA in MDCK cells transfected with pCR-NP-
copper
2 omeg
410 HUANG ET AL.vRNA was confirmed by RT-PCR performed using prim-
ers specific to the M gene and template consisting of
total RNA extracted from the cells and treated with
DNase. The results indicated that M1, NP, and vRNA
were expressed in vitro and in vivo from the plasmid
constructs and that NP and vRNA could be expressed in
the same cells via pCR-NP-vRNA.
The system developed for the studies presented here
is well designed for investigating the effect of M1 on the
nuclear export of RNP, because it eliminates the possi-
bility that other viral proteins may be present in the cell.
FIG. 7. Electron micrographs of negatively stained samples illustra
(NP1vRNA1M1); (B) the oligomers corresponding to fraction 7 in Fig. 6
ing to RNP in the fraction 12 in Fig. 6B (NP1vRNA1M1); (D) the samp
(E) the native RNPs (arrowheads) corresponding to fraction 12 in Fig. 3
absence of plasmid. Samples were adsorbed onto Formvar-coated
Microscience Division, Cambridge, MA) and examined in a LEO EM91MDCK cells stably expressing NP alone or NP and vRNA
(as described under Materials and Methods) were trans-fected with the plasmid pCR-M expressing M1. Localiza-
tion of NP and M1 was determined by double staining
with the antibodies specific to NP and to M1 and sec-
ondary antibodies labeled with fluorescein or rhodamine.
Figure 9 illustrates the immunofluorescent images of the
cellular distribution of NP and M1 using confocal micros-
copy. In the MDCK cells coexpressing M1, NP, and vRNA,
both NP (Fig. 9A in green) and M1 (Fig. 9C in red) were
found abundantly in cytoplasm of the cells and only little
NP and M1 remained in the nuclei of such cells. Colo-
calization of NP and M1 in the cytoplasm was confirmed
the oligomers from fractions corresponding to fraction 7 in Fig. 6B
M1); (C) the higher order helical structures (arrowheads) correspond-
esponding to fraction 12 in Fig. 6A (NP1M1) in the absence of vRNA;
RNP purified from A/PR/8 virus); and (F) the translation sample in the
grids, negatively stained with 2% methylamine tungstate (Bio-Rad
a transmission electron microscope. The bar represents 100 nm.te (A)
A (NP1
le corr
(intactby panel E (merged panels A and C). However, in MDCK
cells coexpressing M1 and NP without also expressing
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411RIBONUCLEOPROTEIN FORMATION AND NUCLEAR EXPORTvRNA, NP was prominently located in the nucleus (Fig.
9B), while the majority of M1 was found in the cytoplasm
(Fig. 9D).
Taken altogether, these results suggest that the for-
mation and transport of RNP requires a three-way inter-
action of NP, M1, and vRNA. Furthermore, the results
suggest that the assembly of RNP and its transport from
nucleus to cytoplasm can occur in the absence of viral
proteins other than NP and M1. NP self-assembles into
oligomers whether or not vRNA is present. However,
interactions of NP with M1 in the presence of vRNA
promote the formation of higher order helical structures
characteristic of RNP.
DISCUSSION
Several experimental approaches have been utilized
to express NP and vRNA and to investigate the formation
of RNP and its biological activities. NP has been synthe-
sized by infection of cells with recombinant viruses
(Huang et al., 1990, de la Lunna et al., 1993), by expres-
ion of the NP gene using polymerase II-driven con-
FIG. 8. Immunofluorescence staining of MDCK cells with transient o
by transfection of the pCR-M plasmid using LipofectAmine Plus reagen
stably expressed in the MDCK cells under the control of the cytomega
(A) or mouse anti-NP monoclonal antibody (B and C), and with donkey an
with rhodamine. Cellular distribution of immunofluorescence was de
source. Magnification, 3472.tructs (Kimura et al., 1992; Pleschka et al., 1996), and by
xpression of NP using vaccinia virus-expression sys-
R
Rems (Mena et al., 1994; Ortega et al., 2000). Similarly,
nfluenza vRNA segments have been produced using a
NA construct driven by polymerase I (Flick et al., 1996)
nd terminated by a ribozyme sequence (Pleschka et al.,
996). However, none of these systems permits an anal-
sis of the intermediate steps in formation of RNP. To
tudy the self-assembly of NP in vitro, NP can be purified
rom virion RNP (Ruigrok and Baudin, 1995). Similar to
ur experience with in vitro translation of NP, NP pro-
omers derived from virions assemble into circular struc-
ures. NP purified from virions has been shown to as-
emble into helical structures but under in vitro condi-
ions of high concentration of input NP (Ruigrok and
audin, 1995). In contrast, the circular form of NP oli-
omers appears to be a relatively thermodynamically
table form, because the circular structure develops
ven at low concentrations of the NP and at physiolog-
cal temperature of 37°C (Ruigrok and Baudin, 1995).
xperimental systems using NP recovered from virion
annot completely avoid residual contamination with
ther viral components that may contribute to or facilitate
expression of M1 or NP. The M1 was transiently expressed in MDCK
o-BRL) for 16 h. The NP or NP-vRNA (CMV/NP or CMV/NP-vRNA) was
(CMV) promoter. The cells were incubated with rabbit anti-M antibody
it IgG conjugated with fluorescein or donkey anti-rabbit IgG conjugated
d with a transmission microscope under an epifluorescent UV lightr stable
t (Gibc
lovirus
ti-rabbNP assembly. Therefore, other approaches to study
NP self-assembly and nuclear export, such as the yeast
and B
ication
412 HUANG ET AL.two-hybrid system (Elton et al., 1999), reverse genetic
techniques (Neumann et al., 2000), and the system we
present here, are needed to determine the contribution
of individual viral components to the process of RNP
formation and transport.
To directly study the self-assembly and morphology of
NP and the individual and combined effects of vRNA and
M1 on RNP formation, we developed a reconstitution
system using in vitro translated NP and M1 and in vitro
transcribed vRNA. In this controlled system, the in vitro
synthesized proteins can be used directly for reconstitu-
tion of RNP without need for further purification. Although
cellular proteins in the translation reaction mixture might
be expected to interfere with functions of the viral pro-
teins, we were, nevertheless, able to detect structures
that in conformation and density were similar to native
RNP. However, the relative inefficiency of production of
FIG. 9. Effect of M1 on the cellular distribution of NP with or without
grown on glass coverslips to 75% confluence. The cells were then trans
The cells were incubated with mouse anti-NP monoclonal antibody (A
(A and C) are merged in E, whereas B and D are merged in F. MagnifRNP in the system suggests that other products of the
translation system may have limited the production ofRNP. Alternatively, the relative inefficiency of this minimal
system may reflect the need for other viral proteins or
functions for optimal RNP production. In addition, the in
vitro system may not completely reflect the more com-
plex in vivo circumstance.
Although the NP concentrations achieved in our ex-
perimental system are putatively low compared to nor-
mal viral infection, NP in the form of small circular oli-
gomers was readily observed, which suggests that dur-
ing normal viral infection the NP oligomers may
assemble before NP reaches maximum concentrations.
As shown in our studies, M1, another viral protein, or
RNA is not required for self-assembly of the circular
oligomers of NP. In our studies, NP oligomers remained
in the form of small circles even with the addition of
vRNA. Since helical structures were produced only when
M1 was added to NP in the presence of vRNA, it is
The cells expressing NP/vRNA (A and C) or NP alone (B and D) were
with pCR-M to express M1 under the control by CMV promoter for 16 h.
in green) or rabbit anti-M antibody (C and D in red). Confocal images
, 3472.vRNA.
fectedsuggested that the sequence of events may be formation
of NP oligomers with subsequent ordered binding of
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413RIBONUCLEOPROTEIN FORMATION AND NUCLEAR EXPORTvRNA and M1. The formation of helical RNP from
NP1vRNA suggests that M1 may bind directly to NP and
vRNA (Ye et al., 1999).
Since M1 facilitates formation of helical RNP, we hy-
pothesize that M1 functions to pull NP oligomers to-
gether to permit formation of the helical structure (Com-
pans et al., 1972; Rees and Dimmock, 1982, Ruigrok and
Baudin, 1995; Schulze, 1972, 1973; Ye et al., 1999) Possi-
bly, this also requires a dimerization of M1 to bind the
layers of the helix together (Compans and Klenk, 1979,
Lamb and Choppin, 1983; Ruigrok and Baudin, 1995).
Although intermediate complexes of NP oligomers and
M1 were not identified by electron microscopy, shifting of
M1 from a lower density to a higher density in the middle
of the gradient corresponding to the location of oli-
gomers of NP (Fig. 6 B) suggests formation of the inter-
mediate complexes of NP1vRNA oligomers and M1.
Judging by the densities of the [35S]Met-labeled M1 and
P, and the percentage of the methionine amino acid
esidues within the proteins (Fig. 6B fraction 12), the ratio
f NP to M1 in the reconstituted RNP complex was
pproximately five NP molecules for every one M1 mol-
cule. If the average circular NP oligomer contains 10 NP
olecules (Ortega et al., 2000; Ruigrok and Baudin,
995), there would be two M1 molecules for each circular
ligomer. If this calculation is correct, it would indicate
hat it takes the interaction of two M1 molecules to bring
ini-RNPs together to form a mature RNP. However, the
inal concentration of M1 in the mature virion is greater
han M1 in RNP complexes so that additional decoration
f RNP complexes with M1 may occur either during
orphogenesis of RNP or by way of membrane-associ-
ted M1 during the budding of virus from the infected
ell.
The interaction of M1 with NP is central to assembly
nd disassembly during the replication cycle of influenza
iruses. The RNP binding of M1 not only plays a struc-
ural role in viral assembly, but in our cell-line expression
ystem, which permits study of the export of RNP without
otential effects from other viral proteins, M1 also ap-
ears to participate in the transport of RNP from nucleus
o cytoplasm. By immunofluorescent staining of cell lines
xpressing NP or expressing NP1vRNA, we can confirm
hat vRNA alone is insufficient for transport of NP from
ucleus to cytoplasm. Colocalization of M1 with NP in
ells expressing M1 and NP1vRNA, but not in cells
xpressing M1 and NP alone, indicates that the interac-
ion between M1 and NP1vRNA in the absence of other
iral proteins is sufficient for the export of RNP from the
ucleus to the cytoplasm. Recent studies (Elton et al.,
001) show that NP export is mediated by a direct inter-
ction between NP and the cellular CRM1 (chromosome
egion maintenance 1 protein). Neumann et al. (2000)
lso conclude that nuclear NP accumulation in cellsnfected with NS-deficient particles is not due to the lack
f M1 but to the lack of NS2 protein. We most certainlyid identify NP in the cytoplasm of cells also expressing
RNA and M1. Since our system had no possibility of
xpression of NS2, we are forced to conclude that nu-
lear export of RNP can occur in the absence of NS2,
ven if the absence of NS2 has been associated with
uclear accumulation of NP in cells used to express
efective virus-like particles (Neumann et al., 2000).
owever, the sequence of events during influenza virus
eplication in cells must be more complex, and it seems
ikely that maturation and transport of RNP in the influ-
nza virus infected cell may require interactions of other
iral and cellular proteins that remain to be fully eluci-
ated.
The requirement for M1 and vRNA in maturation and
he translocation of RNP as shown in our studies sug-
ests that the RNA and RNP-binding domains of M1 have
mportant roles in viral assembly. Bui et al. (2000) have
hown that RNP tightly binds to nuclear matrix, and a
ombination of the detergent, high salt, and DNase is
eeded to extract vRNP from the nucleus. It is tempting
o postulate that the maturation of RNP in the nucleus
nd the translocation of RNP from the nucleus may be
elated sequentially such that M1 binds to NP circular
ligomers and displaces the maturing RNP from the
uclear matrix. Further study is needed to determine
hether modifications of RNP-binding domains of M1
lter RNP formation and translocation.
MATERIALS AND METHODS
iruses and MDCK cells expressing influenza virus
roteins and viral RNAs
Influenza virus A/Puerto Rico/8/34 (PR8) was propa-
ated in the allantoic cavities of nine-day-old embryonic
ggs at 34°C for 2 days. Virions in allantoic fluid were
urified and concentrated by banding in 15–60% sucrose
radient (Ye et al., 1999). Madin–Darby canine kidney
cells, a cell line fully permissive for influenza virus rep-
lication, were grown and maintained in MEM supple-
mented with 5% fetal bovine serum. Stable cell lines
expressing NP or NP1vRNA were established by trans-
fecting MDCK cells with appropriate plasmids described
below and selected by geneticin (G418 sulfate) sensitiv-
ity.
Plasmids
The cDNAs of NP and M genes were cloned from PR8
using RT-PCR. Plasmids pCR-NP or pCR-M, encoding for
the NP or M of PR8, were cloned by insertion of NP or
M-cDNA into the polylinker site of the pCR3.1 vector
(Invitrogen) downstream from the cytomegalovirus (CMV)
and phage T7 promoters. To express viral RNA, the
negative orientation of M-cDNA was cloned into the
polylinker site of the pCR3.1 vector (pCR-vRNA) or down-
stream of the NP gene of the pCR-NP plasmid (pCR-NP-
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414 HUANG ET AL.vRNA). Full-length vRNA was catalyzed by ribozyme
cloned into both ends of the M gene insert (Chowrira et
al., 1994; Shippy et al., 1998). The activity of the ribozyme
equences in the plasmid constructs, pCR-vRNA and
CR-NP-vRNA, was examined by the addition of 6 mM
gCl2 to the transcription reaction mixture followed by
lectrophoresis and autoradiography. The sequence of
and NP were confirmed before in vitro expression in a
oupled transcription and translation system (Promega).
he newly synthesized proteins were analyzed by SDS–
AGE and autoradiography. The expression of vRNA from
CR-vRNA and pCR-NP-vRNA were analyzed by in vitro
ranscription (METAscript TM system, Ambion) in the
resence of [32P]UTP. vRNA produced in vitro was sep-
arated by agarose gel electrophoresis, transferred to
nitrocellulose membranes, and visualized by autoradiog-
raphy.
Purification of RNP from influenza virus
RNPs of influenza virus were obtained by disrupting
PR8 virus (0.5 mg/ml) in 10 mM Tris–HCl (pH 7.4), 1%
Nonidet P-40, 0.6 M NaCl, and 1.25 mM dithiothreitol.
After incubation in disruption buffer for 40 min at room
temperature, released RNPs were concentrated by cen-
trifugation through a 25–50% glycerol gradient in an SW
55Ti rotor at 120,000 g for 60 min and resuspended in 10
M Tris–HCl (pH 7.4). The concentrated RNPs were
ooled and stored at 220°C for later use.
econstitution of RNP with in vitro synthesized NP
nd vRNA
NP used in the reconstitution of RNP was synthesized
rom pCR-NP in the presence of [35S]Met. vRNA for re-
constitution of RNP was transcribed from pCR-vRNA in-
dividually or coexpressed with NP from pCR-NP-vRNA in
a coupled transcription translation system. As a negative
control, NP without vRNA was synthesized from pCR-NP.
As a nonspecific RNA control, a 1011 nucleotide RNA
was synthesized from a plasmid, LITMUS-29 (New En-
gland Biolabs), linearized by BspHI restriction enzyme
digestion. To study the effect of M1 in RNP reconstitution,
M1 was coexpressed with NP and vRNA or nonspecific
RNA in a reaction mixture containing both the pCR-NP-
vRNA and the pCR-M plasmids. The amounts of NP and
M1 in the reaction mixtures were optimized by the level
of NP and M1 expressed individually in separate reac-
tions. Approximately 0.75–2.25 mg of the plasmid DNAs
as utilized for the reaction. One hundred microliters of
eaction mixture containing NP, M1, and vRNA was ad-
usted with solution A (10 mM MgCl2, 10 mM Tris–HCl,
pH 7.8, 10 mM NaCl, 0.1 mM EDTA, and 1 mM DTT in 10%
glycerol) containing a 13 concentration of protease in-
ibitor cocktail (Roche Molecular Biochemicals) to a final
olume of 0.2 ml and incubated at 37°C for 10 min to
olubilize NP (Ruigrok and Baudin, 1995). Each sampleas then cooled from 37 to 4°C over 30 min and held at
°C overnight with agitation. The polymerized RNPs
ere concentrated by centrifugation at 38,000 rpm in a
W55Ti rotor at 4°C for 60 min, resuspended in 50 ml of
buffer A, centrifuged through 30–65% glycerol continuous
gradient in a 0.5 ml tube at 4°C 160,000 g for 16 h, and
fractionated. Aliquots were examined by SDS–PAGE, fol-
lowed by autoradiography or electron microscopy.
Preparation of polyclonal antibodies to oligopeptides
of M1
Synthetic peptides with sequences corresponding to
M1 amino acids, 25–40 (AQRLEDVFAGKNTDLF), and 90–
108 (PNNMDKAVKLYRKLKREIT), were previously pre-
pared by the University of Virginia Biomedical Support
Facility (Ye et al., 1987). The peptides were coupled to
bovine serum albumin (BSA) with glutaraldehyde. Briefly,
1 ml of a 20 mM aqueous solution of glutaraldehyde was
added dropwise over 20 min to a 2 ml solution of crys-
tallized BSA (15 mg/ml) containing a 10- to 40-fold molar
excess of peptide in 100 mM sodium phosphate, pH 7.4.
The reaction mixture was then subjected to exhaustive
dialysis against PBS for 48 h in 30,000 MW cutoff dialysis
tubing. Polyclonal antibodies to peptide–BSA were gen-
erated by injecting l mg of peptide–BSA conjugate with
complete Freund’s adjuvant intradermally into two-
month-old New Zealand white rabbits. Booster injections
containing 0.5 mg of peptide–BSA emulsified in incom-
pleted Freund’s adjuvant were administered at 4, 7, and
10 weeks after primary immunization. Exsanguination
was carried out at 5 or 11 weeks after the initial immu-
nization. Clarification of whole blood was accomplished
by allowing coagulation followed by centrifugation at
18,000 g for 20 min at 4°C. Anti-BSA immunoglobulins
were removed by BSA-linked Sepharose affinity chroma-
tography.
Immunofluorescent staining
MDCK cells expressing influenza virus NP or M1 were
grown on glass coverslips overnight before fixing with
freshly prepared 4% formaldehyde in phosphate-buffered
saline (PBS) for 20 min at room temperature. Cells were
rinsed three times in PBS and permeabilized in PBS
containing 0.5% Nonidet P-40 for 5 min. Background
staining was blocked with 3% powdered skim milk in
PBS for 1 h. The cells were then incubated at room
temperature for 40 min with rabbit anti-M1 antibody or
mouse anti-NP monoclonal antibody (MAb 46/4). The
cells were incubated with donkey anti-rabbit IgG conju-
gated with rhodamine or donkey anti-mouse IgG conju-
gated with fluorescence and incubated for 40 min at
room temperature. Washed coverslips were mounted in
90% glycerol and 10% PBS in 3,4,5-trihydroxybenzoic acid
N-propylester to prevent photobleaching. Cellular distri-
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415RIBONUCLEOPROTEIN FORMATION AND NUCLEAR EXPORTbution of immunofluorescence was determined with a
Bio-Rad MRC 1024 laser confocal microscope.
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